semaglutide andrew huberman The Science of Hunger & Medications to Combat Obesity | Dr. Zachary Knight When the Medication Turns Down

Anyone following a peptide dosing protocol alongside their GLP-1 medication should ensure supplementation does not interfere with other compounds they may be using

Nicotinamide (niacinamide) does not cause flushing and has fewer side effects, with nausea and liver toxicity reported only at very high intakes ~3 g/day)

Thyroid nodules lumps in the thyroid gland

SEE TREATMENT SEE TREATMENT Oral BPC-157 Oral BPC-157 is a peptide therapy used to support the bodys natural recovery processes

trial protocol (500 mg/day is between the 250 mg and 1,000 mg doses studied)

By interfering with the processes that lead to the degradation of proteins, IGF-1 LR3 helps to preserve existing muscle mass, allowing for a net gain in muscle tissue